博雅生物：董事暨总裁任辉辞任，任职未满一年

Core Viewpoint - The announcement from Boya Bio-Pharmaceutical Group indicates a significant leadership change with the resignation of President Ren Hui due to work-related reasons, effective February 26, 2026 [1] Group 1 - Ren Hui submitted a written resignation report to the board, resigning from his positions as a director, president, legal representative, and member of the Strategic and ESG Committee [1] - Ren Hui was appointed as president of Boya Bio in May 2025, with an original term set to end on March 20, 2027 [1] - After his resignation, Ren Hui will not hold any positions within the company and did not own any shares in Boya Bio [1]